Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2020-08-20 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1, which is a Certification of Annual Filings for a Venture Issuer. It is a certification letter by the CEO confirming the review and fair presentation of the annual filings for the financial year ended April 30, 2020. The document does not contain actual financial statements or detailed financial data but is a certification attesting to the accuracy and completeness of the annual filings. It explicitly states it is a certification and does not include representations related to internal controls. Given the document's nature as a certification letter rather than the actual annual report or financial statements, it fits the criteria for a Regulatory Filing (RNS) under the Certification Rule. The document length is short (3111 characters), and it is not the report itself but a certification related to the annual filings. Therefore, the correct classification is Regulatory Filings (RNS).
2020-08-20 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1, which is a Certification of Annual Filings for a Venture Issuer. It is a certification letter by the CFO confirming the review and fair presentation of the annual filings for the financial year ended April 30, 2020. The document does not contain actual financial statements or detailed financial data but is an attestation related to the annual filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports. The document length is 3117 characters, which is relatively short and consistent with a certification letter rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-08-20 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis prepared as of August 20, 2020' and contains detailed discussion of the company's operations, financial position, outlook, and financial results for the year ended April 30, 2020. It includes financial data such as revenues, expenses, net loss, and statement of financial position. It also discusses corporate activities, financings, and forward-looking statements. The presence of detailed financial analysis and management commentary indicates this is a Management Discussion and Analysis (MD&A) report. According to the filing definitions, this corresponds to Management Reports (MDA). The document is 15,000 characters long, so it is not a brief announcement or a report publication announcement. It contains substantive financial data and analysis, not just references or certifications. Therefore, the correct classification is MDA with high confidence.
2020-08-20 English
Audited annual financial statements – English.pdf
Annual Report Classification · 100% confidence The document contains consolidated financial statements for the year ended April 30, 2020, including statements of financial position, loss and comprehensive loss, changes in shareholders' equity, cash flows, and notes to the financial statements. It also includes an Independent Auditor's Report with an opinion on the financial statements, audit basis, and auditor responsibilities. The presence of full financial statements and detailed audit opinion indicates this is a full annual report. The document is about 15,000 characters long, which is consistent with a full report rather than a short announcement. Therefore, this document is classified as an Annual Report (10-K equivalent). FY 2020
2020-08-20 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS - PARTICIPATION FEE' and contains a management certification by the CEO of Izotropic Corporation. It includes detailed market value calculations for specified trading periods and references to OSC Rule 13-502 Fees. The content is primarily a certification and fee calculation form submitted to a securities commission, not a financial report or earnings release. It does not contain financial statements or substantive financial data but is a regulatory filing related to fees and certification. Therefore, it fits best under Regulatory Filings (RNS).
2020-08-20 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to reporting issuers and participation fees, submitted to the Alberta Securities Commission. It includes a management certification by the CEO, Robert Thast, certifying the completeness and accuracy of the information. The document contains detailed trading period data, market values, and issuer information. It is primarily a regulatory filing with certification and financial data related to securities trading and reporting issuer status. There is no indication that this is an annual report, earnings release, or other financial report type. The presence of a management certification and regulatory form submission aligns with the Regulatory Filings (RNS) category, which covers officer certifications and miscellaneous regulatory documents that do not fit other categories.
2020-08-20 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.